TrialCirculation. Heart failure2012

PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design.

Margaret M Redfield et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.